Cargando…

Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping

BACKGROUND: Trofile(® )is the prospectively validated HIV-1 tropism assay. Its use is limited by high costs, long turn-around time, and inability to test patients with very low or undetectable viremia. We aimed at assessing the efficiency of population genotypic assays based on gp120 V3-loop sequenc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Prosperi, Mattia CF, Bracciale, Laura, Fabbiani, Massimiliano, Di Giambenedetto, Simona, Razzolini, Francesca, Meini, Genny, Colafigli, Manuela, Marzocchetti, Angela, Cauda, Roberto, Zazzi, Maurizio, De Luca, Andrea
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907304/ https://www.ncbi.nlm.nih.gov/pubmed/20591141 http://dx.doi.org/10.1186/1742-4690-7-56

Ejemplares similares

Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study
por: Prosperi, Mattia CF, et al.
Publicado: (2012)

The Threshold Bootstrap Clustering: A New Approach to Find Families or Transmission Clusters within Molecular Quasispecies
por: Prosperi, Mattia C. F., et al.
Publicado: (2010)

Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)

Population and ultra-deep sequencing for tropism determination are correlated with Trofile ES: genotypic re-analysis of the A4001078 maraviroc study
por: Portsmouth, S, et al.
Publicado: (2010)

Stability of unfrozen whole blood DNA for remote genotypic analysis of HIV-1 coreceptor tropism
por: Meini, Genny, et al.
Publicado: (2013)

Evaluation of emotion processing in HIV-infected patients and correlation with cognitive performance
por: Baldonero, Eleonora, et al.
Publicado: (2013)

A single gp120 residue can affect HIV-1 tropism in macaques
por: Del Prete, Gregory Q., et al.
Publicado: (2017)

Single-tablet regimen is associated with reduced efavirenz withdrawal in antiretroviral naïve or switching for simplification HIV-infected patients
por: Fabbiani, M, et al.
Publicado: (2012)

A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen
por: Prosperi, Mattia CF, et al.
Publicado: (2011)

An unprecedented and simple gp120 switch mechanism enables HIV-1 to overcome multiple entry inhibitors and tropism limitations
por: Platt, Emily, et al.
Publicado: (2006)

Interaction of the gp120 V1V2 loop with a neighboring gp120 unit shields the HIV envelope trimer against cross-neutralizing antibodies
por: Rusert, Peter, et al.
Publicado: (2011)

Molecular Recognition of CCR5 by an HIV-1 gp120 V3 Loop
por: Tamamis, Phanourios, et al.
Publicado: (2014)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

No evidence of SARS-CoV-2 circulation in HIV-infected patients between December 2019 and February 2020 in Rome, Italy
por: Lombardi, Francesca, et al.
Publicado: (2021)

Structural Descriptors of gp120 V3 Loop for the Prediction of HIV-1 Coreceptor Usage
por: Sander, Oliver, et al.
Publicado: (2007)

Structural Dynamics of HIV-1 Envelope Gp120 Outer Domain with V3 Loop
por: Yokoyama, Masaru, et al.
Publicado: (2012)

Clustering of HIV-1 Subtypes Based on gp120 V3 Loop electrostatic properties
por: López de Victoria, Aliana, et al.
Publicado: (2012)

The Influence of N-Linked Glycans on the Molecular Dynamics of the HIV-1 gp120 V3 Loop
por: Wood, Natasha T., et al.
Publicado: (2013)

Curcumin improves synaptic plasticity impairment induced by HIV-1gp120 V3 loop
por: Shen, Ling-ling, et al.
Publicado: (2015)

Contribution of the gp120 V3 loop to envelope glycoprotein trimer stability in primate immunodeficiency viruses
por: Bowder, Dane, et al.
Publicado: (2018)

Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice
por: Borghetti, Alberto, et al.
Publicado: (2021)

Focusing the immune response on the V3 loop of HIV-1 gp120 induces cross-clade neutralizing
por: Zolla-Pazner, Susan, et al.
Publicado: (2006)

Cryptic Determinant of α4β7 Binding in the V2 Loop of HIV-1 gp120
por: Tassaneetrithep, Boonrat, et al.
Publicado: (2014)

Insights into the Structure, Correlated Motions, and Electrostatic Properties of Two HIV-1 gp120 V3 Loops
por: López de Victoria, Aliana, et al.
Publicado: (2012)

Physiological Corticosterone Attenuates gp120-Mediated Microglial Activation and Is Associated with Reduced Anxiety-Like Behavior in gp120-Expressing Mice
por: Moss, Emaya M., et al.
Publicado: (2023)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study
por: Latini, Alessandra, et al.
Publicado: (2016)

Eliciting neutralizing antibodies with gp120 outer domain
por: Qin, Y, et al.
Publicado: (2012)

Internalization and Axonal Transport of the HIV Glycoprotein gp120
por: Berth, Sarah, et al.
Publicado: (2015)

Effect of Lysine to Arginine Mutagenesis in the V3 Loop of HIV-1 gp120 on Viral Entry Efficiency and Neutralization
por: Schwalbe, Birco, et al.
Publicado: (2015)

Computational study of HIV gp120 as a target for polyanionic entry inhibitors: Exploiting the V3 loop region
por: Hollingsworth, Louis R., et al.
Publicado: (2018)

Allosteric Modulation of the HIV-1 gp120-gp41 Association Site by Adjacent gp120 Variable Region 1 (V1) N-Glycans Linked to Neutralization Sensitivity
por: Drummer, Heidi E., et al.
Publicado: (2013)

Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trial
por: Fabbiani, Massimiliano, et al.
Publicado: (2014)

Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study
por: Lombardi, Francesca, et al.
Publicado: (2016)

The global burden of HIV-1 drug resistance in the past 20 years
por: Zazzi, Maurizio, et al.
Publicado: (2018)

Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis
por: Zaccarelli, Mauro, et al.
Publicado: (2014)

Durable cytotoxic immune responses against gp120 elicited by recombinant SV40 vectors encoding HIV-1 gp120 ± IL-15
por: McKee, Hayley J, et al.
Publicado: (2004)

Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41
por: Pu, Jing, et al.
Publicado: (2019)

Convergent HIV-1 Evolution upon Targeted Destabilization of the gp120-gp41 Interface
por: Torrents de la Peña, Alba, et al.
Publicado: (2021)

Accurate and efficient gp120 V3 loop structure based models for the determination of HIV-1 co-receptor usage
por: Masso, Majid, et al.
Publicado: (2010)

CXCR4 Recognition by L- and D-Peptides Containing the Full-Length V3 Loop of HIV-1 gp120
por: Zhu, Ruohan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sq5plr6631b59t3l6uav332t65